Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
Date | Form | Description | Docs | XBRL | Pages |
08/15/13 | 4 | Rhodes John B |
![]() ![]() |
2 | |
08/15/13 | 4 | Mario Ernest |
![]() ![]() |
2 | |
08/15/13 | 4 | Lederman Seth |
![]() ![]() |
2 | |
08/15/13 | 4 | Daugherty Bruce |
![]() ![]() |
2 | |
08/14/13 | 10-Q | Quarterly report pursuant to sections 13 or 15(d) |
![]() ![]() |
![]() ![]() ![]() |
29 |
08/14/13 | 8-K | Current report filing |
![]() ![]() |
6 | |
08/14/13 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
11 | |
08/13/13 | SC 13G | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
![]() ![]() |
18 | |
08/09/13 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
![]() ![]() |
129 | |
08/09/13 | 8-K | Current report filing |
![]() ![]() |
5 |